Elevated Fasting Blood Glucose Levels Are Associated With Lower Cognitive Function, With a Threshold in Non-Diabetic Individuals: A Population-Based Study

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/52788

言語	英語
著者	Liu Ziyi Molecular Neuroscience Research Center, Shiga University of Medical Science Department of Public Health, Shiga University of Medical Science Zaid Maryam Center for Epidemiologic Research in Asia, Shiga University of Medical Science Hisamatsu, Takashi Center for Epidemiologic Research in Asia, Shiga University of Medical Science Department of Environmental Medicine and Public Health, Faculty of Medicine, Shimane University Tanaka, Sachiko Department of Medical Statistics, Shiga University of Medical Science Fujiyoshi, Akira Department of Public Health, Shiga University of Medical Science Miyagawa, Naoko Department of Public Health, Shiga University of Medical Science Ito, Takahiro Department of Public Health, Shiga University of Medical Science Kadota, Aya Department of Public Health, Shiga University of Medical Science Center for Epidemiologic Research in Asia, Shiga University of Medical Science Tooyama, Ikuo Molecular Neuroscience Research Center, Shiga University of Medical Science Miura, Katsuyuki Center for Epidemiologic Research in Asia, Shiga University of Medical Science Ueshima, Hirotsugu Department of Public Health, Shiga University of Medical Science Center for Epidemiologic Research in Asia, Shiga University of Medical Science
主題	cognitive abilities screening instrument (CAST); cognitive function; diabetes mellitus; fasting blood glucose
掲載誌名	JOURNAL OF EPIDEMIOLOGY
巻	30
号	3
開始ページ	121
終了ページ	127
ISSN	0917-5040
発行日	2020-03
DOI	10.2188/jea.JE20180193
PubMed ID	31130559
出版者	JAPAN EPIDEMIOLOGICAL ASSOC
資料タイプ	学術雑誌論文
部局	医学部
備考	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology Japan [grant numbers (A) 13307016, (A) 17209023, (A) 21249043, (A) 23249036, (A) 25253046, (A) 15H02528, (A) 15H04773, (B) 26293140, (B) 23390174, and (C) 23590790] and by National Institutes of Health, USA [grant number R01HL068200], and by GlaxoSmithKline.